Top Three Sources Of Evidence Suggesting Natural Killer Cells Role In Parkinson's Prevention
Source: QPS LLC
According to the Global Burden of Disease study, 6.2 million patients live with Parkinson’s disease (PD) and this number is expected to double by 2040. Although promising medications, such as levadopa, have been introduced, there are currently no cures for PD. Researchers at the University of Georgia are trying to change that with their recent discovery of how specialized immune cells in our bodies, known as natural killer cells, operate to fight the protein clumping that is a hallmark of PD. To find out more, read the available blog post.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
QPS LLC
This website uses cookies to ensure you get the best experience on our website. Learn more